Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Carlson

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 3, 2013
Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancerBrian J Linder, Stephen A Boorjian, Eric C Umbreit, et al.
The Journal of Urology|January 23, 2010
The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen eraStephen A Boorjian, R Jeffrey Karnes, Paul L Crispen, et al.
Oncology|December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patientsAminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 21, 2016
Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancerDharam Kaushik, Stephen A Boorjian, R Houston Thompson, et al.
Urology|August 22, 2017
Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical MarginBimal Bhindi, Rachel E Carlson, Ross J Mason, et al.
BMJ Open Gastroenterology|July 17, 2024
Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage StudyKathleen J Yost, Rachel E Carlson, Christine R Kirt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 23, 2019
A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy SpecimensRafael E Jimenez, Thomas D Atwell, Hughes Sicotte, et al.
The Journal of Urology|January 2, 2016
Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?Amir Toussi, Suzanne B Stewart-Merrill, Stephen A Boorjian, et al.
European Urology Focus|July 21, 2017
Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume HospitalsBoris Gershman, Sarah P Psutka, Francis J McGovern, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Urology : Official Journal of the Japanese Urological Association|January 3, 2013
Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancerBrian J Linder, Stephen A Boorjian, Eric C Umbreit, et al.
The Journal of Urology|January 23, 2010
The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen eraStephen A Boorjian, R Jeffrey Karnes, Paul L Crispen, et al.
Oncology|December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patientsAminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 21, 2016
Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancerDharam Kaushik, Stephen A Boorjian, R Houston Thompson, et al.
Urology|August 22, 2017
Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical MarginBimal Bhindi, Rachel E Carlson, Ross J Mason, et al.
BMJ Open Gastroenterology|July 17, 2024
Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage StudyKathleen J Yost, Rachel E Carlson, Christine R Kirt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 23, 2019
A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy SpecimensRafael E Jimenez, Thomas D Atwell, Hughes Sicotte, et al.
The Journal of Urology|January 2, 2016
Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?Amir Toussi, Suzanne B Stewart-Merrill, Stephen A Boorjian, et al.
European Urology Focus|July 21, 2017
Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume HospitalsBoris Gershman, Sarah P Psutka, Francis J McGovern, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
Pageof 3